Skip to main content
. 2022 Jun 28;3:100116. doi: 10.1016/j.crphar.2022.100116

Table 3.

Psychopathological changes and Effect Sizes for efficacy measures in patients receiving alpha-lipoic acid at baseline and week 12.


Baseline (T0)
Week 12 (T1)
Wilcoxon test T0 vs T1
Cohen’s d
Mean S.D. Mean S.D. p
PANSS
Positive 12.40 3.02 13.20 5.55 .776 0.2
Negative 20.40 11.95 20.80 13.08 .776 0
Gen. Psychopathology 40.00 14.36 40.80 20.73 .798 0
Total score 72.80 28.64 74.80 34.21 .719 0.1